🟢 Echo IQ is trading 6.12% up today with FDA clearance still an upcoming catalyst

Echo IQ is trading A$1.56 (+6.12%), rebounding from the A$1.47 August 7, 2026 close without a clear August 10, 2026 company announcement explaining the move.

• Its latest major development remains the August 5, 2026 FDA 510(k) submission for EchoSolv HF, incorporating clinical-validation results.
• Coverage describes FDA clearance as an important upcoming catalyst, not a new approval.
• Broader markets were broadly flat, providing limited support for a global explanation.